119
By Arthur Tzianabos, CEO of Lifordi Immunotherapeutics, as part of the From the Trenches feature of LifeSciVC
Well, this is a first…. while I have read and enjoyed the the LifeSci VC blog for years, being asked to contribute for the first time yielded a ‘holy crap’ moment in the ‘be careful what you wish for’ category. For those of you out there who know me, you know that I am not afraid to share my view and opinion. Now that there is a platform to do so…let us see how it goes. I was afforded this opportunity as a result of jumping in as CEO of a Series A newco that was formed by ARCH Venture Partners, Atlas Venture and 5AM…